Skip to search formSkip to main contentSkip to account menu

Simulect

National Institutes of Health

Related topics

Related topics

2 relations
basiliximabbasiliximab 20 MG Injection [Simulect]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Antithymocyte antibody-induced coagulopathy in renal transplant recipients.
2010
2010
Outcome of the using older donors for kidney transplantation;Gazi University, Ankara experience.
2007
2007
Efficacy and safety of simulect in renal transplation recipients treated with induction therapy
Objective To evaluate the efficacy and the safety of BasiliXimab (Simulect) as part of a quadruple induction regimen. Methods… 
2005
2005
Application of simulect in liver transplantation patients
Objective To evaluate the efficacy and safety of simulect (basiliximab) after orthotopic liver transplantation (OLT). Methods… 
2005
2005
[Effect of cyclosporine and simulect mono and combination therapy on cardiac allo-transplantation in rats].
OBJECTIVE To observe the effect of cyclosporine and simulect mono or combination therapy on cardiac allo-transplantation in rats… 
2005
2005
Basiliximab (Simulect) in acute tubular necrosis high-risk kidney transplantation.
2005
2005
Basiliximab (Simulect) reduces acute rejection among sensitized kidney allograft recipients.
2004
2004
Use of simulect can reduce the incidence of acute rejection and demonstrates with superior 3-year patient and graft survival rates in renal transplantation.
2003
2003
Anti-CD25 monoclonal antibody modulates cytokine expression and prolongs allografts survival in rats cardiac transplantation.
OBJECTIVE To investigate the role of anti- interleukin-2 receptor (CD25) monoclonal antibody in the regulation of cytokine mRNA… 
1999
1999
Development and validation of an immunoreceptor assay for simulect based on surface plasmon resonance.
Simulect is a chimeric human/mouse antibody directed against interleukin-2 (IL-2) receptor. A combined immuno- and receptor assay… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)